Two cases of pemphigoid nodularis

Miki Kohno, Masakazu Takahara, Masayoshi Nakao, Ayako Kameda, Tomoko Saito, Kyoko Kudo, Shiori Kato, Takeshi Nakahara, Uchi Hiroshi, Yoichi Moroi, Masutaka Furue

Research output: Contribution to journalArticle

Abstract

We report two cases of pemphigoid nodularis with anti-BP180 antibody and prurigo-like nodules preceding the development of blisters. Case 1 : A 62-year-old woman with a 2-year history of pruritic nodules on her trunk, extremities, and head, which had been treated as prurigo nodularis, developed blisters on her thighs. She was diagnosed as having pemphigoid nodularis, based on results that included increased titer of serum anti-BP180 antibody (ELISA), histopathology, and direct and indirect immunofluorescence. The blisters cleared after treatment with oral prednisolone (5 mg/day) and minocycline (150 mg/day) but recurred duringthe taperingof the dose of minocycline. After the prednisolone dose was raised to 15 mg/day, the nodules quickly improved. Case 2 : In March 2007, a 55-year-old woman had pruritic nodules on the upper extremities, which gradually extended to the entire body. She had been resistant to treatment with topical steroids and narrow band UVB under the initial diagnosis of prurigo nodularis, while blisters appeared on the extremities in June 2007. After the diagnosis of pemphigoid nodularis was made, treatment with oral prednisolone (25 mg/day) and minocycline (100 mg/day) was initiated, which resulted in clearance of the blisters. When the blisters recurred in April 2010, oral prednisolone (50 mg/day) cleared the blisters. However, because severe pruritus and nodules remained, prednisolone was exchanged for betamethasone, leadingto a partial resolution. Consideringthe previous reports, pruritic nodules appear first and blisters develop later in many cases. When clinical manifestations consist only of pruritic nodules, anti-BP180 antibody (ELISA) and immunofluorescence are valuable tools to diagnose pemphigoid nodularis.

Original languageEnglish
Pages (from-to)129-133
Number of pages5
JournalNishinihon Journal of Dermatology
Volume75
Issue number2
DOIs
Publication statusPublished - Jan 1 2013

Fingerprint

Bullous Pemphigoid
Blister
Prednisolone
Prurigo
Minocycline
Anti-Idiotypic Antibodies
Extremities
Enzyme-Linked Immunosorbent Assay
Betamethasone
Direct Fluorescent Antibody Technique
Pruritus
Indirect Fluorescent Antibody Technique
Thigh
Upper Extremity
Fluorescent Antibody Technique
Therapeutics
Steroids
Head

All Science Journal Classification (ASJC) codes

  • Dermatology

Cite this

Kohno, M., Takahara, M., Nakao, M., Kameda, A., Saito, T., Kudo, K., ... Furue, M. (2013). Two cases of pemphigoid nodularis. Nishinihon Journal of Dermatology, 75(2), 129-133. https://doi.org/10.2336/nishinihonhifu.75.129

Two cases of pemphigoid nodularis. / Kohno, Miki; Takahara, Masakazu; Nakao, Masayoshi; Kameda, Ayako; Saito, Tomoko; Kudo, Kyoko; Kato, Shiori; Nakahara, Takeshi; Hiroshi, Uchi; Moroi, Yoichi; Furue, Masutaka.

In: Nishinihon Journal of Dermatology, Vol. 75, No. 2, 01.01.2013, p. 129-133.

Research output: Contribution to journalArticle

Kohno, M, Takahara, M, Nakao, M, Kameda, A, Saito, T, Kudo, K, Kato, S, Nakahara, T, Hiroshi, U, Moroi, Y & Furue, M 2013, 'Two cases of pemphigoid nodularis', Nishinihon Journal of Dermatology, vol. 75, no. 2, pp. 129-133. https://doi.org/10.2336/nishinihonhifu.75.129
Kohno M, Takahara M, Nakao M, Kameda A, Saito T, Kudo K et al. Two cases of pemphigoid nodularis. Nishinihon Journal of Dermatology. 2013 Jan 1;75(2):129-133. https://doi.org/10.2336/nishinihonhifu.75.129
Kohno, Miki ; Takahara, Masakazu ; Nakao, Masayoshi ; Kameda, Ayako ; Saito, Tomoko ; Kudo, Kyoko ; Kato, Shiori ; Nakahara, Takeshi ; Hiroshi, Uchi ; Moroi, Yoichi ; Furue, Masutaka. / Two cases of pemphigoid nodularis. In: Nishinihon Journal of Dermatology. 2013 ; Vol. 75, No. 2. pp. 129-133.
@article{651db99cd9044429987632c9d32d88b1,
title = "Two cases of pemphigoid nodularis",
abstract = "We report two cases of pemphigoid nodularis with anti-BP180 antibody and prurigo-like nodules preceding the development of blisters. Case 1 : A 62-year-old woman with a 2-year history of pruritic nodules on her trunk, extremities, and head, which had been treated as prurigo nodularis, developed blisters on her thighs. She was diagnosed as having pemphigoid nodularis, based on results that included increased titer of serum anti-BP180 antibody (ELISA), histopathology, and direct and indirect immunofluorescence. The blisters cleared after treatment with oral prednisolone (5 mg/day) and minocycline (150 mg/day) but recurred duringthe taperingof the dose of minocycline. After the prednisolone dose was raised to 15 mg/day, the nodules quickly improved. Case 2 : In March 2007, a 55-year-old woman had pruritic nodules on the upper extremities, which gradually extended to the entire body. She had been resistant to treatment with topical steroids and narrow band UVB under the initial diagnosis of prurigo nodularis, while blisters appeared on the extremities in June 2007. After the diagnosis of pemphigoid nodularis was made, treatment with oral prednisolone (25 mg/day) and minocycline (100 mg/day) was initiated, which resulted in clearance of the blisters. When the blisters recurred in April 2010, oral prednisolone (50 mg/day) cleared the blisters. However, because severe pruritus and nodules remained, prednisolone was exchanged for betamethasone, leadingto a partial resolution. Consideringthe previous reports, pruritic nodules appear first and blisters develop later in many cases. When clinical manifestations consist only of pruritic nodules, anti-BP180 antibody (ELISA) and immunofluorescence are valuable tools to diagnose pemphigoid nodularis.",
author = "Miki Kohno and Masakazu Takahara and Masayoshi Nakao and Ayako Kameda and Tomoko Saito and Kyoko Kudo and Shiori Kato and Takeshi Nakahara and Uchi Hiroshi and Yoichi Moroi and Masutaka Furue",
year = "2013",
month = "1",
day = "1",
doi = "10.2336/nishinihonhifu.75.129",
language = "English",
volume = "75",
pages = "129--133",
journal = "Nishinihon Journal of Dermatology",
issn = "0386-9784",
publisher = "Kyushu University, Faculty of Science",
number = "2",

}

TY - JOUR

T1 - Two cases of pemphigoid nodularis

AU - Kohno, Miki

AU - Takahara, Masakazu

AU - Nakao, Masayoshi

AU - Kameda, Ayako

AU - Saito, Tomoko

AU - Kudo, Kyoko

AU - Kato, Shiori

AU - Nakahara, Takeshi

AU - Hiroshi, Uchi

AU - Moroi, Yoichi

AU - Furue, Masutaka

PY - 2013/1/1

Y1 - 2013/1/1

N2 - We report two cases of pemphigoid nodularis with anti-BP180 antibody and prurigo-like nodules preceding the development of blisters. Case 1 : A 62-year-old woman with a 2-year history of pruritic nodules on her trunk, extremities, and head, which had been treated as prurigo nodularis, developed blisters on her thighs. She was diagnosed as having pemphigoid nodularis, based on results that included increased titer of serum anti-BP180 antibody (ELISA), histopathology, and direct and indirect immunofluorescence. The blisters cleared after treatment with oral prednisolone (5 mg/day) and minocycline (150 mg/day) but recurred duringthe taperingof the dose of minocycline. After the prednisolone dose was raised to 15 mg/day, the nodules quickly improved. Case 2 : In March 2007, a 55-year-old woman had pruritic nodules on the upper extremities, which gradually extended to the entire body. She had been resistant to treatment with topical steroids and narrow band UVB under the initial diagnosis of prurigo nodularis, while blisters appeared on the extremities in June 2007. After the diagnosis of pemphigoid nodularis was made, treatment with oral prednisolone (25 mg/day) and minocycline (100 mg/day) was initiated, which resulted in clearance of the blisters. When the blisters recurred in April 2010, oral prednisolone (50 mg/day) cleared the blisters. However, because severe pruritus and nodules remained, prednisolone was exchanged for betamethasone, leadingto a partial resolution. Consideringthe previous reports, pruritic nodules appear first and blisters develop later in many cases. When clinical manifestations consist only of pruritic nodules, anti-BP180 antibody (ELISA) and immunofluorescence are valuable tools to diagnose pemphigoid nodularis.

AB - We report two cases of pemphigoid nodularis with anti-BP180 antibody and prurigo-like nodules preceding the development of blisters. Case 1 : A 62-year-old woman with a 2-year history of pruritic nodules on her trunk, extremities, and head, which had been treated as prurigo nodularis, developed blisters on her thighs. She was diagnosed as having pemphigoid nodularis, based on results that included increased titer of serum anti-BP180 antibody (ELISA), histopathology, and direct and indirect immunofluorescence. The blisters cleared after treatment with oral prednisolone (5 mg/day) and minocycline (150 mg/day) but recurred duringthe taperingof the dose of minocycline. After the prednisolone dose was raised to 15 mg/day, the nodules quickly improved. Case 2 : In March 2007, a 55-year-old woman had pruritic nodules on the upper extremities, which gradually extended to the entire body. She had been resistant to treatment with topical steroids and narrow band UVB under the initial diagnosis of prurigo nodularis, while blisters appeared on the extremities in June 2007. After the diagnosis of pemphigoid nodularis was made, treatment with oral prednisolone (25 mg/day) and minocycline (100 mg/day) was initiated, which resulted in clearance of the blisters. When the blisters recurred in April 2010, oral prednisolone (50 mg/day) cleared the blisters. However, because severe pruritus and nodules remained, prednisolone was exchanged for betamethasone, leadingto a partial resolution. Consideringthe previous reports, pruritic nodules appear first and blisters develop later in many cases. When clinical manifestations consist only of pruritic nodules, anti-BP180 antibody (ELISA) and immunofluorescence are valuable tools to diagnose pemphigoid nodularis.

UR - http://www.scopus.com/inward/record.url?scp=84882960766&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84882960766&partnerID=8YFLogxK

U2 - 10.2336/nishinihonhifu.75.129

DO - 10.2336/nishinihonhifu.75.129

M3 - Article

VL - 75

SP - 129

EP - 133

JO - Nishinihon Journal of Dermatology

JF - Nishinihon Journal of Dermatology

SN - 0386-9784

IS - 2

ER -